RCE 0.00% 47.0¢ recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-101

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,380 Posts.
    lightbulb Created with Sketch. 692
    I was hoping after initial batch there would have been a notice of no adverse events. Maybe it takes time to collate data, and also maybe there are some reactions that they are yet to decide if they are classed as adverse? I would guess patients may "feel" something different but they may not know for some time if it is a reaction or any detrimental effect? Maybe they are still waiting for confirmation all is ok with initial batch. One would have to assume if second cohort proceeds then first must have been deemed safe, but I guess we have no conformation second cohort is going ahead so who knows.
    Bottom line seems to be surely if there had Ben a serious adverse effect they would have been obliged to notify when they became aware.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
47.0¢
Change
0.000(0.00%)
Mkt cap ! $108.9M
Open High Low Value Volume
47.5¢ 47.5¢ 46.0¢ $77.35K 164.2K

Buyers (Bids)

No. Vol. Price($)
1 49974 46.5¢
 

Sellers (Offers)

Price($) Vol. No.
47.0¢ 37899 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.